Analyst Recommendations

Barclays analyst issues OVERWEIGHT recommendation for AZN on January 6, 2026 06:35PM ET. The previous analyst recommendation was Overweight.AZN was trading at $94.42 at issue of the analyst...

January 6, 2026   AZN -0.16%

Morgan Stanley analyst issues OVERWEIGHT recommendation for MT on January 6, 2026 05:26PM ET. The previous analyst recommendation was Overweight.MT was trading at $47.925 at issue of the...

January 6, 2026   MT -4.90%

Barclays analyst issues UNDERWEIGHT recommendation for GSK on January 6, 2026 04:50PM ET. The previous analyst recommendation was Equal-Weight.GSK was trading at $50.52 at issue of the analyst...

January 6, 2026   GSK -0.13%

Jefferies analyst issues BUY recommendation for TEVA on January 6, 2026 12:37PM ET. The previous analyst recommendation was Buy.TEVA was trading at $31 at issue of the analyst...

January 6, 2026   TEVA -1.06%

Morgan Stanley analyst issues OVERWEIGHT recommendation for BLTE on January 6, 2026 10:00AM ET. BLTE was trading at $159.42 at issue of the analyst recommendation.The overall analyst consensus...

January 6, 2026   BLTE 7.34%

Morgan Stanley analyst issues OVERWEIGHT recommendation for RTO on January 6, 2026 09:37AM ET. RTO was trading at $30.15 at issue of the analyst recommendation.The overall analyst consensus...

January 6, 2026   RTO -4.32%

RBC Capital analyst issues OUTPERFORM recommendation for DEO on January 6, 2026 09:44AM ET. The previous analyst recommendation was Sector Perform.DEO was trading at $89.55 at issue of...

January 6, 2026   DEO -2.11%

Bradesco analyst issues OUTPERFORM recommendation for OMAB on January 5, 2026 10:15PM ET. OMAB was trading at $109.26 at issue of the analyst recommendation.The overall analyst consensus :...

January 5, 2026   OMAB -0.18%

Bradesco analyst issues NEUTRAL recommendation for PAC on January 5, 2026 10:15PM ET. The previous analyst recommendation was Outperform.PAC was trading at $262.45 at issue of the analyst...

January 5, 2026   PAC -0.79%

Bradesco analyst issues OUTPERFORM recommendation for ASR on January 5, 2026 10:14PM ET. The previous analyst recommendation was Outperform.ASR was trading at $323.86 at issue of the analyst...

January 5, 2026   ASR -1.49%